International Journal of Science and Research Archive,
Год журнала:
2024,
Номер
12(2), С. 1232 - 1235
Опубликована: Июль 30, 2024
The
filamentous
fungus
that
causes
Mucormycosis
is
a
newly
discovered
angiogenic
infection
found
in
large
quantities
and
member
of
the
Zygomycete
class's
Mucorales
order.
In
patients
undergoing
hematopoietic
allogeneic
stem
cell
transplantation,
after
candidiasis
aspergillosis,
mucormycosis
has
become
third
most
common
invasive
mycosis.
Breathing
sporangiospores
daily
need.
remarkably
low
frequency
members
nasal
mucus
indicates
airborne
contamination
either
minimal
or
mucociliary
transport
removes
spores
from
airway
mucus.
this
review
research,
new
approaches
to
assessing
relationships
among
host,
fungus,
antifungal
drugs
are
provided.
Aerosols
other
novel
delivery
methods
might
also
aid
treatment
mucormycosis.
Clinical Radiology & Imaging Journal,
Год журнала:
2023,
Номер
7(2)
Опубликована: Янв. 1, 2023
Mucormycosis
an
opportunistic
mycosis,
has
emerged
as
a
significant
concern
among
severely
immune
compromised
individuals,
particularly
those
with
hematologic
malignancies
or
who
have
undergone
stem
cell
organ
transplantation.
In
this
case
report,
we
present
rare
of
pulmonary
mucormycosis
complicated
by
abscess
formation
in
middle-aged
male
medical
history
Acute
Myeloid
Leukemia
(AML).
The
imaging
findings
revealed
non-specific
fungal
infection,
and
the
pathology
report
confirmed
diagnosis
mucormycosis.
Subsequently,
patient
underwent
successful
left
upper
lobectomy
is
currently
stable
condition.
Baylor University Medical Center Proceedings,
Год журнала:
2024,
Номер
37(2), С. 348 - 354
Опубликована: Янв. 8, 2024
Mucormycosis
is
an
invasive
fungal
infection
that
can
cause
acute
clinical
decompensation
and
death.
The
literature
demonstrates
case
fatality
rates
around
50%
with
differential
courses
contingent
upon
anatomical
incursion.
Rhino-orbital
cerebral
mucormycosis
represents
a
rapidly
hostile
variant
poorer
outcomes,
warranting
prompt
recognition,
workup,
intervention.
It
seldom
included
in
diagnoses
those
head
neck
pathology
within
the
inpatient
setting
as
diagnostic
parsimony
low
prevalence
lead
this
entity
to
be
often
overlooked.
Given
acuity
risk
factors
involved,
considering
may
prudent
during
assessment
of
hyperglycemic
or
immunodeficient
patients
exhibiting
maxillofacial
disease.
When
acquiring
histories
presenting
illness
performing
physical
examinations,
includes
mindfulness
diabetes
mellitus,
craniofacial
lesions,
alertness
deterioration.
rising
incidence
complicated
mellitus
conjunction
paucity
reports
noting
orbit
harbinger,
we
report
59-year-old
woman
admitted
critical
care
for
diabetic
ketoacidosis
altered
mental
status.
Physical
examination
revealed
swollen
orbit,
later
diagnosed
associated
sino-orbit
involvement
cranial
nerve
deficits
urgent
extensive
facial
debridement.
Indian Journal of Anatomy and Surgery of Head Neck and Brain,
Год журнала:
2024,
Номер
9(4), С. 112 - 116
Опубликована: Фев. 15, 2024
The
outbreak
of
COVID-19,
caused
by
the
novel
coronavirus
SARS-CoV-2,
has
been
linked
to
a
notable
rise
in
mucormycosis
cases,
particularly
evident
during
second
wave
summer
2021.
Mucormycosis,
characterized
its
aggressive
nature
and
high
mortality
rates,
requires
rapid
identification
intervention.
Factors
such
as
poorly
controlled
blood
sugar
levels,
corticosteroid
usage,
COVID-19-related
immune
compromise
are
significant
contributors
development.
objective
this
review
is
analyze
incidence,
progression,
clinical
manifestations,
treatment
approaches
mucormycosis,
drawing
from
selection
16
pertinent
articles
published
between
2009
2022,
accessed
through
databases
like
PubMed
Google
Scholar.
Journal of Pharmaceutical Care,
Год журнала:
2024,
Номер
unknown
Опубликована: Июль 2, 2024
The
outbreak
of
opportunistic
fungal
infections
such
as
mucormycosis
has
been
a
critical
issue
following
coronavirus
disease
19
(COVID-19).
Mucormycosis
is
happened
by
the
group
Mucorales
and
commonly
affects
immunocompromised
patients.
To
date,
COVID-19-associated
(CAM)
being
reported
in
several
countries.
It
should
be
noted
that
CAM
started
patients
approximately
within
two
to
three
weeks
after
onset
COVID-19.
However,
here,
one
case,
symptoms
appeared
just
week.
In
with
due
this
enigmatic
infection,
sinuses
were
most
affected,
followed
orbit,
nose,
finally
brain.
All
cases
received
glucocorticoids
part
viral
therapy.
Diabetes
mellitus
(DM)
was
all
but
case
which
COVID-19
detected,
without
complications,
may
sole
predisposing
agent.
Therefore,
manuscript,
we
eight
COVID-19-induced
mucormycosis.
Although
experienced
evacuation
right
eye,
others
discharge
promising
outcomes
receiving
surgical
debridement
proper
anti-fungal
treatment
including,
amphotericin
B,
caspofungin,
posaconazole.
International Journal of Science and Research Archive,
Год журнала:
2024,
Номер
12(2), С. 1232 - 1235
Опубликована: Июль 30, 2024
The
filamentous
fungus
that
causes
Mucormycosis
is
a
newly
discovered
angiogenic
infection
found
in
large
quantities
and
member
of
the
Zygomycete
class's
Mucorales
order.
In
patients
undergoing
hematopoietic
allogeneic
stem
cell
transplantation,
after
candidiasis
aspergillosis,
mucormycosis
has
become
third
most
common
invasive
mycosis.
Breathing
sporangiospores
daily
need.
remarkably
low
frequency
members
nasal
mucus
indicates
airborne
contamination
either
minimal
or
mucociliary
transport
removes
spores
from
airway
mucus.
this
review
research,
new
approaches
to
assessing
relationships
among
host,
fungus,
antifungal
drugs
are
provided.
Aerosols
other
novel
delivery
methods
might
also
aid
treatment
mucormycosis.
